How to Take Your Best Shot

Caffrey, Rose Marie
November 2004
Diabetes Health;Nov2004, Vol. 13 Issue 11, p66
Presents several tips in choosing the right insulin syringe for people with diabetes. Information on syringe size; Explanation on needle gauge; Significance of using short needle.


Related Articles

  • Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency. Juhl, Claus B.; Porksen, Niels; Hollingdal, Malene; Sturis, Jeppe; Pincus, Steven; Veldhuis, Johannes D.; Dejgaard, Anders; Schmitz, Ole; Juhl, C B; Pørksen, N; Hollingdal, M; Sturis, J; Pincus, S; Veldhuis, J D; Dejgaard, A; Schmitz, O // Diabetes Care;May2000, Vol. 23 Issue 5, p675 

    Objective: Repaglinide is a new oral hypoglycemic agent that acts as a prandial glucose regulator proposed for the treatment of type 2 diabetes by stimulating insulin secretion. The aim of this study was to explore actions of repaglinide on the rapid pulsatile insulin release by...

  • Insulin-requiring diabetes in Ethiopia: associations with poverty, early undernutrition and anthropometric disproportion. Fekadu, S.; Yigzaw, M.; Alemu, S.; Dessie, A.; Fieldhouse, H.; Girma, T.; Trimble, E. R.; Phillips, D. I. W.; Parry, E. H. O. // European Journal of Clinical Nutrition;Oct2010, Vol. 64 Issue 10, p1192 

    Background/Objectives:Most insulin-requiring diabetes patients in Ethiopia have an atypical form of the disease, which resembles previous descriptions of malnutrition-related diabetes. As so little is known about its aetiology, we have carried out a case-control study to evaluate its social and...

  • Antihyperglycaemic use up but varied in Europe.  // PharmacoEconomics & Outcomes News;10/21/2006, Issue 514, p6 

    The article reveals that the overall use of antihyperglycaemic drugs has increased over time in Europe, but large differences in use between countries are apparent, according to a study conducted by a multinational group of researchers. In England and Germany, the use of insulin doubled over the...

  • Challenge calls for discovery of new insulin.  // Endocrine Today;Oct2011, Vol. 9 Issue 10, p19 

    The article focuses on the 100,000 U.S. dollar challenge announced by the Juvenile Diabetes Research Foundation and InnoCentive to look for innovative ways to approach the discovery and development of a glucose-responsive insulin to treat diabetes.

  • Clinical Q & A.  // Drug Topics;11/20/2000, Vol. 114 Issue 22, p41 

    Answers a question on the difference of insulin glargine and insulin aspart from the older insulins. Characteristic of diabetes mellitus (DM); Insulin products used in the treatment of DM; Number of people in the United States affected by the disease.

  • IGF-I linked to long-term stroke recovery. Fisher, Stacey L.; Foster, Melissa; Kalvaitis, Katie // Endocrine Today;Aug2011, Vol. 9 Issue 8, p29 

    The article offers information on a study that associated high levels of insulin like growth factor I and better long-term recovery from stroke.

  • Improved Postprandial Glycemic Control With Insulin Aspart. Lindholm, Anders; McEwen, John; Riis, Anders P. // Diabetes Care;May99, Vol. 22 Issue 5, p801 

    Presents information on a study which compared the postprandial serum glucose control after administration of insulin aspart, a rapid-acting insulin analog, with that of unmodified human insulin in patients with type one diabetes. Research design and methods; Results; Conclusions.

  • soluble insulin.  // Royal Society of Medicine: Medicines;2002, p504 

    The article presents information on soluble insulin, a form of purified bovine and/or porcine insulin or human insulin, prepared as a sterile solution. This drug is used in diabetic treatment to maintain diabetic patients. Administration is by injection. It has a short-acting duration of action.

  • Avoiding, spotting and managing hypos. Rowlandson, Fiona // Practice Nurse;8/17/2007, Vol. 34 Issue 3, p20 

    The article focuses on diagnosing, managing and preventing hypo or hypoglycaemic. A person with diabetes experiences a hypo attack when their blood glucose concentration falls below 4mmol/l. Many symptoms of hypoglycaemia mimic the effects of alcohol, so a person developing a hypo may appear...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics